Allodynic Therapeutics Revenue

Pharmaceutical Manufacturing • North Miami, Florida, United States • 1-10 Employees

Allodynic Therapeutics revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$547,552
Total funding	No funding

Key Contact at Allodynic Therapeutics

Annette Toledano

Founder and Chief Medical Officer

Company overview

Headquarters	1785 NE 123rd St, North Miami, Florida, US
Phone number	+13058956808
Website	allodynic.com
NAICS	3254
SIC	283
Keywords	Non-Addictive Pain Treatmetns
Founded	2010
Employees	1-10
Socials

About Allodynic Therapeutics

Allodynic Therapeutics is a clinical-stage biopharma company engaged in developing naltrexone-acetaminophen (ALLOD-2) as an oral investigational product for the acute treatment of migraine. Both naltrexone and acetaminophen individually can simultaneously reduce physical and emotional pain, potentially enhancing treatment outcomes. Naltrexone-acetaminophen U.S. patents extend to 2037.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Allodynic Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Allodynic Therapeutics has never raised funding before.

Allodynic Therapeutics Tech Stack

Discover the technologies and tools that power Allodynic Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

Gnuboard

CMS

lit-element

JavaScript libraries

Google Maps

Maps

lit-html

JavaScript libraries

jQuery Migrate

JavaScript libraries

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

Perl

Programming languages

PHP

Programming languages

WordPress

Blogs

Bootstrap

UI frameworks

Frequently asked questions

Allodynic Therapeutics is located in North Miami, Florida, US.

You can reach Allodynic Therapeutics at +13058956808.

Allodynic Therapeutics generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

Allodynic Therapeutics has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Allodynic Therapeutics was founded in 2010, making it 16 years old. The company has established itself as a significant player in its industry over this time.

Allodynic Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Allodynic Therapeutics

Annette Toledano

Founder and Chief Medical Officer

4.8

40,000 users